GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioAdaptives Inc (OTCPK:BDPT) » Definitions » Gross Margin %

BioAdaptives (BioAdaptives) Gross Margin % : 42.86% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is BioAdaptives Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. BioAdaptives's Gross Profit for the three months ended in Dec. 2023 was $0.00 Mil. BioAdaptives's Revenue for the three months ended in Dec. 2023 was $0.01 Mil. Therefore, BioAdaptives's Gross Margin % for the quarter that ended in Dec. 2023 was 42.86%.


The historical rank and industry rank for BioAdaptives's Gross Margin % or its related term are showing as below:

BDPT' s Gross Margin % Range Over the Past 10 Years
Min: 37.5   Med: 41.18   Max: 50
Current: 39.29


During the past 9 years, the highest Gross Margin % of BioAdaptives was 50.00%. The lowest was 37.50%. And the median was 41.18%.

BDPT's Gross Margin % is ranked better than
76.71% of 1808 companies
in the Consumer Packaged Goods industry
Industry Median: 25.085 vs BDPT: 39.29

BioAdaptives had a gross margin of 42.86% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for BioAdaptives was 0.00% per year.


BioAdaptives Gross Margin % Historical Data

The historical data trend for BioAdaptives's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioAdaptives Gross Margin % Chart

BioAdaptives Annual Data
Trend Dec13 Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 50.00 37.50 50.00 41.18 37.93

BioAdaptives Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.00 66.67 50.00 31.25 42.86

Competitive Comparison of BioAdaptives's Gross Margin %

For the Packaged Foods subindustry, BioAdaptives's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioAdaptives's Gross Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Gross Margin % distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Gross Margin % falls into.



BioAdaptives Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

BioAdaptives's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0 / 0.029
=(Revenue - Cost of Goods Sold) / Revenue
=(0.029 - 0.018) / 0.029
=37.93 %

BioAdaptives's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0 / 0.007
=(Revenue - Cost of Goods Sold) / Revenue
=(0.007 - 0.004) / 0.007
=42.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioAdaptives  (OTCPK:BDPT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioAdaptives had a gross margin of 42.86% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


BioAdaptives Gross Margin % Related Terms

Thank you for viewing the detailed overview of BioAdaptives's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioAdaptives (BioAdaptives) Business Description

Traded in Other Exchanges
N/A
Address
2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.
Executives
Richard Chiang other: Previous Officer and Director 460 BRANNAN STREET SUITE 78064, SAN FRANCISCO CA 94107
Barry Epling director 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Ferris Holding Inc. 10 percent owner 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Gerald Epling director, officer: Pres, CEO, Secretary, CFO 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128

BioAdaptives (BioAdaptives) Headlines

From GuruFocus

BioAdaptives Sponsors COVID-19 Long Hauler Survey

By PurpleRose PurpleRose 07-12-2022